Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors
NCT01218529
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Brain Metastases
Lung Tumors
Breast Tumors
Interventions
DRUG:
Lapatinib
Sponsor
Hellenic Cooperative Oncology Group